Bioteque Corporation

NT$104.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4107Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 1.12%
Div yield 5.29%
ROE 17.29%
Medical Instruments & Supplies
Beta (5Y) 0.16
PE TTM 12.30
TSR TTM (11.35%)
Mkt cap NT$7.207B
ROIC 26.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$121
16.40%
(30.95%)
Hold 0|12|7|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.06
1.14
1.21
1.25
7.23%
5.15%
9.78%
13.23%
RevenueNT$M
621.5
653.3
665.4
698.9
10.19%
11.62%
10.34%
11.46%
Peers (US$217.7M)
Cap (US$)
PE
161.6M
12.53x
156.9M
11.85x
208.9M
10.22x
Capital
TTM
5Y
10Y
Leveragex
0.636
0.073
0.071
EBIT/Intx
1.635
0.329
0.318
Own earn%
(34.44)
(130.01)
(108.78)
Sh yield%
41.23
29.57
27.40
Owners
Insiders/Inst%
1.68
68.67
Short interest%
5.96
SBC / revenue%
4.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
8–18
$1 testx
—
Incr. ROIC%
0